Grovepoint Capital

Overview

Grovepoint Capital is a private equity firm headquartered in London, United Kingdom, with additional offices in Israel. Founded in 2010 by Leon Blitz and Bradley Fried, the firm focuses on investments across various sectors, including biotechnology, sports nutrition, retail, and financial services. Grovepoint Capital has a history of providing both equity and credit investments to companies in need of capital for growth, restructuring, or turnaround situations. The firm's investment strategy encompasses a range of stages, from buyouts and growth investments to late-stage and pre-IPO funding. It also engages in turnaround and distressed investments, aiming to revitalize underperforming businesses. Grovepoint Capital's geographical focus includes the United Kingdom and Israel, reflecting its commitment to supporting companies in these regions. Grovepoint Capital has a track record of significant investments, such as acquiring a majority stake in Algatechnologies, an Israeli biotech start-up, in 2013, and in Grenade, a sports nutrition company, in 2014. The firm also provided credit facilities to companies like NKD, a German retailer, and Pure Leisure Group, a British caravan holiday company. In 2018, the credit arm of the business was renamed Bantry Bay Capital, indicating a strategic shift in its investment approach.

Investment Focus

• High growth potential
• Compelling business models
• Sustainable competitive advantages

Portfolio Companies